Peter Kufer

Amgen (Germany) — Germany

Medicine · Health Sciences

53h-index11.6kcitations209works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(126), CAR-T cell therapy research(107), Immunotherapy and Immune Responses(47), Glycosylation and Glycoproteins Research(32), Cancer Immunotherapy and Biomarkers(22)

Publications209 total

Abstract ND06: AMG 305, a dual targeting BiTE®molecule with selective activity for solid tumors that co-express CDH3 and MSLN
Cancer Research·2023· 8 cited
Data from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Supplementary Figure 1 from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Data from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Supplementary Methods, Figure Legend from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Supplementary Figure 1 from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Supplementary Methods, Figure Legend from Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
2023Open Access
Data from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Data from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Data from Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events
2023Open Access
Supplementary Data from Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events
2023Open Access
Supplementary Figure S4 from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Data from A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer
2023Open Access
Supplementary figure and table legends from A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure S3 from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Supplementary figure and table legends from A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure S3 from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Figure S2 from A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer
2023Open Access
Supplementary Methods and Tables from The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
2023Open Access
Data from Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Patrick A. Baeuerle(36), Ralf C. Bargou(18), Gerhard Zugmaier(12), Bernd Schlereth(11), Gert Riethmüller(10), Ralf Lutterbuese(10), Tobias Raum(10), Matthias Klinger(9), Roman Kischel(9), Christian Brandl(8), Klaus Brischwein(8), Andreas Wolf(7), Grit Lorenczewski(7), Doris Rau(7), Andreas Viardot(6), Dirk Nagorsen(6), Robert Hofmeister(6), Patrick Hoffmann(6), Matthias Friedrich(6), Hermann Einsele(5)